These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18356205)

  • 1. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
    Buck S; Rienstra M; Maass AH; Nieuwland W; Van Veldhuisen DJ; Van Gelder IC
    Europace; 2008 May; 10(5):558-65. PubMed ID: 18356205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.
    Borleffs CJ; Ypenburg C; van Bommel RJ; Delgado V; van Erven L; Schalij MJ; Bax JJ
    Heart Rhythm; 2009 Mar; 6(3):305-10. PubMed ID: 19251202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial electromechanical conduction time can predict six-month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography.
    Park SM; Kim YH; Choi JI; Pak HN; Kim YH; Shim WJ
    J Am Soc Echocardiogr; 2010 Mar; 23(3):309-14. PubMed ID: 20138472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
    Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
    Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.
    Kiès P; Leclercq C; Bleeker GB; Crocq C; Molhoek SG; Poulain C; van Erven L; Bootsma M; Zeppenfeld K; van der Wall EE; Daubert JC; Schalij MJ; Bax JJ
    Heart; 2006 Apr; 92(4):490-4. PubMed ID: 16159986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
    Smit MD; Maass AH; Hillege HL; Wiesfeld AC; Van Veldhuisen DJ; Van Gelder IC
    Eur J Heart Fail; 2011 May; 13(5):543-50. PubMed ID: 21330294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation.
    Majos-Karwacka E; Kraska A; Kowalik I; Smolis-Bak E; Lipiec P; Kasprzak J; Szwed H; Dabrowski R
    Scand Cardiovasc J; 2021 Feb; 55(1):15-21. PubMed ID: 32954833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation.
    De Vos CB; Weijs B; Crijns HJ; Cheriex EC; Palmans A; Habets J; Prins MH; Pisters R; Nieuwlaat R; Tieleman RG
    Heart; 2009 May; 95(10):835-40. PubMed ID: 19074923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N; De Diego C; Vaseghi M; Buch E; Cesario DA; Mahajan A; Wiener I; Fonarow GC; Boyle NG; Shivkumar K
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1363-8. PubMed ID: 17976100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure.
    Bertini M; Borleffs CJ; Delgado V; Ng AC; Piers SR; Shanks M; Antoni ML; Biffi M; Boriani G; Schalij MJ; Bax JJ; Van de Veire NR
    Eur J Heart Fail; 2010 Oct; 12(10):1101-10. PubMed ID: 20861134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.
    Hauck M; Bauer A; Voss F; Katus HA; Becker R
    Clin Res Cardiol; 2009 Mar; 98(3):189-94. PubMed ID: 19034378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.